Market closedNon-fractional

Rezolute/RZLT

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Rezolute

Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies. It applies proprietary formulation and manufacturing capabilities to known, well-characterized molecules to create differentiated, patent-protected therapies that have the potential to significantly improve existing standards of care. Its pipeline products include RZ358 and RZ402.

Ticker

RZLT

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology

Headquarters

Redwood City, United States

Employees

41

Rezolute Metrics

BasicAdvanced
$220M
Market cap
-
P/E ratio
-$1.14
EPS
1.31
Beta
-
Dividend rate
$220M
1.31
11.817
11.502
2.567
3.346
-34.67%
-58.75%
2.35
2.35
-4.218
0.63%
-23.57%

What the Analysts think about Rezolute

Analyst Ratings

Majority rating from 7 analysts.
Buy

Rezolute Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
0.00% profit margin
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$0
NaN%
Net income
-$17M
22.30%
Profit margin
0.00%
NaN%

Rezolute Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 11.74%
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
-$0.25
-$0.28
-$0.27
-$0.34
-
Expected
-$0.36
-$0.28
-$0.30
-$0.30
-$0.32
Surprise
-29.78%
-0.88%
-10.99%
11.74%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Rezolute stock?

Rezolute (RZLT) has a market cap of $220M as of July 06, 2024.

What is the P/E ratio for Rezolute stock?

The price to earnings (P/E) ratio for Rezolute (RZLT) stock is 0 as of July 06, 2024.

Does Rezolute stock pay dividends?

No, Rezolute (RZLT) stock does not pay dividends to its shareholders as of July 06, 2024.

When is the next Rezolute dividend payment date?

Rezolute (RZLT) stock does not pay dividends to its shareholders.

What is the beta indicator for Rezolute?

Rezolute (RZLT) has a beta rating of 1.31. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell Rezolute stock

Buy or sell Rezolute stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing